Stay updated on Pyrotinib Combo in HR+/HER2- Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Combo in HR+/HER2- Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a general platform release rather than modifications to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:44.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 to the record history and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:24:56.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was deleted from the Study Record Versions.
    Difference
    0.1%
    Check dated 2026-03-19T04:57:24.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added a new history entry Revision: v3.4.3 and removed Revision: v3.4.2 from the Study Record history.
    Difference
    0.1%
    Check dated 2026-03-12T02:55:06.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the record history. The previous government funding notice (Revision: v3.4.1) was removed.
    Difference
    0.9%
    Check dated 2026-02-11T10:19:59.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    A general site-wide notice about government funding and NIH Clinical Center status was added. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-04T06:41:21.000Z thumbnail image

Stay in the know with updates to Pyrotinib Combo in HR+/HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.